Negative correlation of Nogo-A with the malignancy of oligodendroglial tumor

Neuroscience Bulletin

Volumn 23, Issue 1, 2007, Pages 41-45

  Xiong, Nan Xiang ^a   Zhao, Hong Yang ^a   Zhang, Fang Cheng ^a   He, Zhu Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Immunohistochemistry; Nogo A; Oligodendroglial tumors

Indexed keywords

PROTEIN NOGO A;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; MALE; MITOSIS; OLIGODENDROGLIOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; BRAIN NEOPLASMS; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOTIC INDEX; MYELIN PROTEINS; NEOPLASM INVASIVENESS; OLIGODENDROGLIOMA; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 33847767699     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-007-0006-1     Document Type: Article

References (15)

1. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000, 403: 439-444.
2. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 27: 403: 434-439.
3. Li Q, Qi B, Oka K, Shimakage M, Yoshioka N, Inoue H. Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 2001, 20: 3929-3936.
4. Oertle T, Merkler D, Schwab ME. Do cancer cells die because of Nogo-B? Oncogene 2003, 22: 1390-1399.
5. Huber AB, Weinmann O, Brosamle C, Oertle T, Schwab ME. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002, 22: 3553-3567.
6. Watari A, Yutsudo M. Multi-functional gene ASY/Nogo/RTN-X/RTN4: apoptosis, tumor suppression, and inhibition of neuronal regeneration. Apoptosis 2003, 8: 5-9.
7. Tambe Y, Isono T, Haraguchi S, Yoshioka-Yamashita A, Yutsudo M, Inoue H. A novel apoptotic pathway induced by the drs tumor suppressor gene. Oncogene 2004, 23: 2977-2987.
8. Amberger VR, Hensel T, Ogata N, Schwab ME. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 1998, 58: 149-158.
9. Liao H, Duka T, Teng FY, Sun L, Bu WY, Ahmed S. Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J Neurochem 2004, 90: 1156-1162.
10. Oertle T, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 2003, 23: 5393-5406.
11. L. and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 2000, 19: 5736-5746.
12. Rousseau S, Peggie M, Campbell DG, Nebreda AR, Cohen P. Nogo-B is a new physiological substrate for MAPKAP-K2. Biochem J 2005, 391 (Pt 2): 433-40.
13. Qi B, Qi Y, Watari A, Yoshioka N, Inoue H, Minemoto Y, et al. Pro-apoptotic ASY/Nogo-B protein associates with ASYIP. J Cell Physiol 2003, 196: 312-218.
14. Teng FY, Tang BL. No go for brain tumors? J Mol Neurosci 2005, 25: 1-6.
15. Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem 2003, 278: 19280-19285.